|
Aminohippurate Sodium Inj 20% Clinical Trials
2 actively recruiting trials across 1 location
Also known as: -Sodium 4-amino hippurate (PAH) inj 20% 2g/10mL -Para-aminohippurate, Aminohippuric acid, Para-aminohippurate, Sodium 4-amino hippurate (PAH) inj 20% 2g/10mL
Aurora, Colorado2 trials
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Children's Hospital Colorado
Renal Mechanism of SGLT2 Inhibition
University of Colorado Denver
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.